Dermatologic Agents Concept

Vocabulary Service

MeSH

Overview

subject area of

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009 Academic Article
A Consensus on Acne Management Focused on Specific Patient Features Academic Article
A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin Academic Article
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. Academic Article
Are Excipients Really Inert Ingredients? A Review of Adverse Reactions to Excipients in Oral Dermatologic Medications in Canada Academic Article
Biologic survival. Academic Article
Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Academic Article
Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors Academic Article
Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys Academic Article
Clinical Significance of Markedly Elevated Serum Creatine Kinase Levels in Patients with Acne on Isotretinoin Academic Article
Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment Academic Article
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study Academic Article
Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis Academic Article
Efficacy Outcomes in Patients Using Alefacept in the AWARE Study Academic Article
Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases Academic Article
Granulocyte–macrophage colony‐stimulating factor ( GM ‐ CSF ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ GM ‐ CSF monoclonal antibody Academic Article
Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis Academic Article
Immunotherapies in Dermatologic Disorders Academic Article
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Academic Article
Interventions for cutaneous disease in systemic lupus erythematosus Academic Article
Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks. Academic Article
Long-term safety of biologics in dermatology Academic Article
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. Academic Article
Newer approaches in topical combination therapy for acne. Academic Article
Non-Traumatic Sixth Nerve Palsy in a Young Patient Academic Article
Novel Management of Isotretinoin-Induced Hypertriglyceridemia in an Adolescent With Severe Acne Academic Article
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy Academic Article
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis Academic Article
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial Academic Article
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics Academic Article
Protection afforded by controlled application of a barrier cream: a study in a workplace setting Academic Article
Psoriasis patients’ preference for an aerosol foam topical formulation Academic Article
Rosacea: update on management and emerging therapies. Academic Article
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE) Academic Article
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study Academic Article
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study Academic Article
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis Academic Article
Topical benzoyl peroxide for acne Academic Article
Topical calcipotriol in childhood psoriasis Academic Article
Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??) Academic Article
VERRUCAE PLANAE OF THE FACE Academic Article
When is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Academic Article